Showing results (71-80 of 115) with videos related to

Sort By:
Pageof 12
Surgical Infections|February 11, 2021
Evaluation of Intra-Operative Topical Vancomycin and the Incidence of Acute Kidney InjuryAlison L Blackman, Manjari Joshi, James Doub, et al.
Surgical Infections|August 21, 2015
Validation of a Dosing Strategy for Cefazolin for Surgery Requiring Cardiopulmonary BypassAllison L Hollis, Emily L Heil, David P Nicolau, et al.
Infectious Diseases and Therapy|May 5, 2019
Dalbavancin Use in Vulnerable Patients Receiving Outpatient Parenteral Antibiotic Therapy for Invasive Gram-Positive InfectionsJacqueline T Bork, Emily L Heil, Shanna Berry, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2020
A Propensity Score Matched Study of the Positive Impact of Infectious Diseases Consultation on Antimicrobial Appropriateness in Hospitalized Patients with Antimicrobial Stewardship OversightJacqueline T Bork, Kimberly C Claeys, Emily L Heil, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 1, 2012
Impact of a rapid peptide nucleic acid fluorescence in situ hybridization assay on treatment of Candida infectionsEmily L Heil, Lindsay M Daniels, Dustin M Long, et al.
Infection Control and Hospital Epidemiology|January 19, 2018
Accuracy of Provider-Selected Indications for Antibiotic OrdersEmily L Heil, Lisa Pineles, Poonam Mathur, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Ceftolozane-Tazobactam Pharmacokinetics in a Critically Ill Patient on Continuous Venovenous HemofiltrationWesley D Oliver, Emily L Heil, Jeffrey P Gonzales, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 7, 2024
Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative InfectionsPranita D Tamma, Emily L Heil, Julie Ann Justo, et al.
Antimicrobial Agents and Chemotherapy|December 1, 2020
Evaluation of Linezolid Pharmacokinetics in Critically Ill Obese Patients with Severe Skin and Soft Tissue InfectionsAlison L Blackman, Praneeth Jarugula, David P Nicolau, et al.
Diagnostic Microbiology and Infectious Disease|October 17, 2017
Impact of CLSI and EUCAST Cefepime breakpoint changes on the susceptibility reporting for EnterobacteriaceaeJacqueline T Bork, Emily L Heil, Surbhi Leekha, et al.
Pageof 12